Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Fullmektig i EP:
2011.08.08, EP 11176803
ELLEN ANCKAERT ET AL: "The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments", HUMAN REPRODUCTION, OXFORD JOURNALS, GB, vol. 27, no. 6, 1 June 2012 (2012-06-01), pages 1829 - 1839, XP002686253, ISSN: 0268-1161, [retrieved on 20120403], DOI: 10.1093/HUMREP/DES101 (B1)
FLACK M R ET AL: "Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 79, no. 3, 1 September 1994 (1994-09-01), pages 756 - 760, XP002494715, ISSN: 0021-972X, DOI: 10.1210/JC.79.3.756 (B1)
FREIESLEBEN N L C ET AL: "Prospective investigation of serum anti-Mullerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study", REPRODUCTIVE BIOMEDICINE ONLINE, REPRODUCTIVE HEALTHCARE LTD, GB, vol. 20, no. 5, 1 May 2010 (2010-05-01), pages 582 - 587, XP027030875, ISSN: 1472-6483, [retrieved on 20100212] (B1)
WO-A1-2012/042381 (B1)
U.S. NATIONAL INSTITUTE OF HEALTH: "A Dose-response Trial Using rFSH FE999049 in Women Undergoing IVF/ICSI Treatment", 30 August 2011 (2011-08-30), XP002666779, Retrieved from the Internet <URL:http://clinicaltrials.gov/ct2/show/NCT01426386?term=fe+999049&rank=1> [retrieved on 20120110] (B1)
US-A1- 2008 108 571 (B1)
WO-A1-2009/127826 (B1)
LA COUR FREIESLEBEN N ET AL: "Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study.", HUMAN REPRODUCTION (OXFORD, ENGLAND) OCT 2009 LNKD- PUBMED:19602518, vol. 24, no. 10, October 2009 (2009-10-01), pages 2523 - 2530, XP002666778, ISSN: 1460-2350 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP4005588)
|
Utgående
EP Registreringsbrev (3210) (PTEP4005588)
|
Innkommende, AR611722135
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 13. avg. år (EP) | 2024.08.20 | 5460 | CPA GLOBAL LIMITED | Betalt og godkjent |
32405481 expand_more expand_less | 2024.04.23 | 7254 | RWS | Betalt |
Valideringsgebyr EP-patent
7150 = 1 X 7150
Gebyr ved bruk av MasterCard-kort
104 = 104 X 1
|